Stay updated on ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Sign up to get notified when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.

Latest updates to the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedLatest version updates core study details such as Study Status and Contacts/Locations, reflecting current recruitment status and site information.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed from the history.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision updated to v3.4.3. The previous v3.4.2 entry is now obsolete.SummaryDifference0.0%

- Check39 days agoChange DetectedThe new version updates the Study Status and Contacts/Locations sections, reflecting the current trial status and site details.SummaryDifference0.0%

- Check61 days agoChange DetectedVersion 86 adds a new 'Study Status' section to the history and removes the prior funding-status notice.SummaryDifference0.5%

- Check68 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP2215 vs Salvage Chemo in AML with FLT3 Mutation Clinical Trial page.